HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabiola Castorena-Torres Selected Research

Phenylephrine (Neo-Synephrine)

5/2010L-arginine and antioxidant diet supplementation partially restores nitric oxide-dependent regulation of phenylephrine renal vasoconstriction in diabetics rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabiola Castorena-Torres Research Topics

Disease

8Neoplasms (Cancer)
02/2024 - 03/2014
2Laron Syndrome (Syndrome, Laron)
05/2019 - 01/2017
2Body Weight (Weight, Body)
03/2014 - 05/2010
1Hepatocellular Carcinoma (Hepatoma)
02/2024
1Amyloid Plaque
12/2023
1Birth Weight (Birth Weights)
01/2022
1Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022
1Maternal Obesity
01/2022
1Insulin Resistance
01/2022
1Lymphocytosis
09/2021
1Carcinogenesis
09/2021
1Bronchopulmonary Dysplasia
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Hyperoxia
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Lung Injury
01/2021
1Tuberculosis (Tuberculoses)
01/2021
1COVID-19
01/2021
1Human Influenza (Influenza)
01/2020
1Gastritis
01/2020
1Hypersensitivity (Allergy)
01/2020
1Infections
01/2020
1Respiratory Tract Diseases (Respiratory Tract Disease)
01/2020
1Drug-Related Side Effects and Adverse Reactions
01/2020
1Obesity
05/2019
1Hyperglycemia
05/2019
1Diabetic Retinopathy (Retinopathy, Diabetic)
05/2019
1Type 2 Diabetes Mellitus (MODY)
05/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2019
1Hearing Loss (Hearing Impairment)
05/2019
1Cataract (Cataracts)
05/2019
1Dyslipidemias (Dyslipidemia)
05/2019
1Transient Tachypnea of the Newborn
04/2018
1Newborn Respiratory Distress Syndrome
04/2018
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2018
1Fanconi Anemia (Fanconi's Anemia)
01/2017
1Nervous System Diseases (Neurological Disorders)
01/2017
1Genomic Instability
01/2017
1Cardiovascular Diseases (Cardiovascular Disease)
03/2014
1Dementia (Dementias)
03/2014
1Neural Tube Defects (Exencephaly)
03/2014
1Diabetic Nephropathies (Diabetic Nephropathy)
05/2010

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
09/2021 - 02/2018
3Insulin (Novolin)FDA Link
12/2023 - 05/2019
3Peptides (Polypeptides)IBA
12/2023 - 01/2017
2Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2023 - 05/2010
2ArsenicIBA
09/2021 - 01/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 05/2010
2Growth Hormone (Somatotropin)IBA
05/2019 - 01/2017
1Sorafenib (BAY 43-9006)FDA Link
02/2024
1Valproic Acid (Depakote)FDA LinkGeneric
02/2024
1Metformin (Glucophage)FDA LinkGeneric
02/2024
1VenomsIBA
12/2023
1CalciumIBA
12/2023
1Potassium Channels (Potassium Channel)IBA
12/2023
1Angiotensin IIIBA
12/2023
1Antiviral Agents (Antivirals)IBA
12/2023
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2022
1Carrier Proteins (Binding Protein)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1Isotretinoin (Accutane)FDA LinkGeneric
09/2021
1Thalidomide (Thalomid)FDA Link
09/2021
1alpha-TocopherolFDA Link
09/2021
1Selenious Acid (Selenite)IBA
09/2021
1LipidsIBA
01/2021
1Ethanol (Ethyl Alcohol)IBA
01/2021
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1indole-3-carbinolIBA
01/2021
1Hand SanitizersIBA
01/2021
1ProdrugsIBA
01/2020
1Oseltamivir (Tamiflu)FDA Link
01/2020
1Epithelial Sodium ChannelsIBA
04/2018
1ZeinIBA
02/2018
1DystrophinIBA
01/2018
1Antihypertensive Agents (Antihypertensives)IBA
01/2017
1Drinking WaterIBA
01/2017
1AntioxidantsIBA
01/2017
1Insulin-Like PeptidesIBA
01/2017
1Folic Acid (Vitamin M)FDA LinkGeneric
03/2014
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
05/2010
1Streptozocin (Streptozotocin)FDA Link
05/2010
1sapropterin (tetrahydrobiopterin)FDA Link
05/2010
1Vasoconstrictor AgentsIBA
05/2010

Therapy/Procedure

1Chemoprevention
01/2020